These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 34234547)

  • 1. High Endothelin Receptor Type A Expression as an Independent Prognostic Biomarker and Correlated with Immune Infiltrates in Stomach Adenocarcinoma.
    Yan Y; Nie K; Zheng J; Jiang X; Huang Y; Zheng Z; Wen Y; Li P
    Cancer Manag Res; 2021; 13():5013-5026. PubMed ID: 34234547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of expression signature and immune microenvironment signature of biomarker Endothelin Receptor Type A in stomach adenocarcinoma.
    Wang Z; Wang K; Yu X; Chen M; Du Y
    J Cancer; 2022; 13(7):2086-2104. PubMed ID: 35517422
    [No Abstract]   [Full Text] [Related]  

  • 3. Comprehensive Characterization of Transforming Growth Factor Beta Receptor 1 in Stomach Adenocarcinoma Identifies a Prognostic Signature for Predicting Clinical Outcomes and Immune Infiltrates.
    He Y; Zhang H; Zhang Y; Wang P; Zhu K; Ba Y
    Int J Gen Med; 2022; 15():3375-3391. PubMed ID: 35368798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UBR1 is a prognostic biomarker and therapeutic target associated with immune cell infiltration in gastric cancer.
    Yuan W; Han J; Chen C; Qiu Y; Xu Y; Huang Y; Chen Z; Xu A; Sun M
    Aging (Albany NY); 2024 Aug; 16(16):12029-12049. PubMed ID: 39181686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine-Like Protein 1 (CYTL1) as a Key Target of M-Stage Immune Infiltration in Stomach Adenocarcinoma.
    Zhou F; Lin Q; Zheng Z
    Biomed Res Int; 2023; 2023():2926218. PubMed ID: 36825034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA DIRC1 is a novel prognostic biomarker and correlated with immune infiltrates in stomach adenocarcinoma.
    Lin Y; Zhang Z; Li Y; Chen Y; Su M; Zhao W
    Medicine (Baltimore); 2022 Nov; 101(46):e31839. PubMed ID: 36401393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a prognostic risk model for Stomach adenocarcinoma based on endoplasmic reticulum stress genes.
    Li X; Lei Y
    Wien Klin Wochenschr; 2024 Jun; 136(11-12):319-330. PubMed ID: 37993598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive bioinformatic analysis of mind bomb 1 gene in stomach adenocarcinoma.
    Wang D; Wang QH; Luo T; Jia W; Wang J
    World J Gastrointest Oncol; 2023 Jul; 15(7):1295-1310. PubMed ID: 37546549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of COMMD10 as a novel prognostic biomarker for gastric cancer.
    Zhao W; Lin J; Cheng S; Li H; Shu Y; Xu C
    PeerJ; 2023; 11():e14645. PubMed ID: 36919165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino acid metabolism-related genes as potential biomarkers and the role of MATN3 in stomach adenocarcinoma: A bioinformatics, mendelian randomization and experimental validation study.
    Zhu W; Fu M; Li Q; Chen X; Liu Y; Li X; Luo N; Tang W; Zhang Q; Yang F; Chen Z; Zhang Y; Peng B; Zhang Q; Zhang Y; Peng X; Hu G
    Int Immunopharmacol; 2024 Dec; 143(Pt 1):113253. PubMed ID: 39353384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
    Han C; Zhang C; Wang H; Li K; Zhao L
    BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Expression of ERK-related RASGRF2 predicts Poor prognosis in patients with Stomach Adenocarcinoma and correlates with M2 macrophage.
    Du Y; Wang Z; Wan W
    J Cancer; 2021; 12(23):7177-7189. PubMed ID: 34729119
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased
    Zhaoran S; Linnebacher CS; Linnebacher M
    Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor 3 is a potential prognosis marker and associated with immune infiltration in stomach adenocarcinoma.
    Huang Z; He A; Wang J; Lu H; Xu X; Zhang R; Liao W; Feng Q; Wu L
    Cancer Biomark; 2022; 34(1):77-93. PubMed ID: 34657879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an immunogenic cell death prognostic signature for predicting clinical outcome and immune infiltration characterization in stomach adenocarcinoma.
    Liu Y; Zhang L; Lei X; Yin X; Liu S
    Aging (Albany NY); 2023 Oct; 15(20):11389-11411. PubMed ID: 37862109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification of stomach adenocarcinoma based on fatty acid metabolism-related genes frofiling.
    Liu C; Tao Y; Lin H; Lou X; Wu S; Chen L
    Front Mol Biosci; 2022; 9():962435. PubMed ID: 36090054
    [No Abstract]   [Full Text] [Related]  

  • 18. IRF7 is a Prognostic Biomarker and Associated with Immune Infiltration in Stomach Adenocarcinoma.
    Guo L; Fang T; Jiang Y; Liu D
    Int J Gen Med; 2021; 14():9887-9902. PubMed ID: 34938108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of the expression, prognostic, and immune infiltration for COL4s in stomach adenocarcinoma.
    Xu Y; Jin H; Chen Y; Yang Z; Xu D; Zhang X; Yang J; Wang Y
    BMC Med Genomics; 2024 Jun; 17(1):168. PubMed ID: 38907304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CFP is a prognostic biomarker and correlated with immune infiltrates in Gastric Cancer and Lung Cancer.
    Cui G; Geng L; Zhu L; Lin Z; Liu X; Miao Z; Jiang J; Feng X; Wei F
    J Cancer; 2021; 12(11):3378-3390. PubMed ID: 33976747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.